Elsevier Publishes Neural Data Science: A Primer with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Elsevier Publishes Neural Data Science: A Primer with MATLAB(R) and Python(TM)

CAMBRIDGE, MA --(Marketwired - March 29, 2017) - Elsevier , the information analytics company specializing in science and health, today announced the publication of Neural Data Science: A Primer with MATLAB® and Python™ by Erik Lee Nylen and Pascal Wallisch. The book offers a beginner's introduction to the principles of computation and data analysis in neuroscience, using both Python and MATLAB in parallel, giving readers the ability to transcend platform tribalism and enable coding versatility. Elsevier also announced the publication of six additional neuroscience books.

Neural Data Science: A Primer with MATLAB® and Python™ introduces the canonical data analysis cascade, standardizing the data analysis flow. The book also presents methods that strategically, tactically and algorithmically help improve the organization of code. It is a valuable resource for students, researchers and instructors in systems, cognitive and behavioral neuroscience, and cognitive psychology.

Learn more about the foundation of neural data science in this sample chapter , "Philosophy," which discusses the current state of neuroscience and the need to integrate it with the emerging field of data science, resulting in the discipline of neural data science.

Dr. Nylen is currently a data scientist in New York, where he also is Executive Co-Director of The Stand, the New York City Dance Marathon. He received his Ph.D. from the Center for Neural Science at New York University, and his B.S.E. and M.S. in Biomedical Engineering at the University of Iowa. Dr. Nylen did a fellowship at Insight Data Science, and has taught at the "Neural Data Science" summer course at Cold Spring Harbor Laboratory. He is a patented inventor and has performed with numerous musical groups.

Dr. Wallisch serves as a professor in the Department of Psychology at New York University, where he currently teaches statistics, programming and the use of mathematical tools in neuroscience and psychology. He received his Ph.D. in Psychology from the University of Chicago and worked as a postdoctoral fellow at the Center for Neural Science at New York University. His long-term commitment to educational excellence was recognized by the "Wayne C. Booth Graduate Student Prize for Excellence in teaching" at the University of Chicago and the "Golden Dozen Award" at New York University. Dr. Wallisch co-founded and co-organizes the "Neural Data Science" summer course at Cold Spring Harbor Laboratory and co-authored the acclaimed book, "Matlab® for Neuroscientists."

The seven new neuroscience titles are:

• Neural Data Science: A Primer with MATLAB® and Python™ by Erik Lee Nylen and Pascal Wallisch

• Molecular and Cellular Therapies for Motor Neuron Diseases by Nicholas Boulis, Deirdre O'Connor and Anthony Donsante

• Stress: Neuroendocrinology and Neurobiology by George Fink

• Neuroprotection in Alzheimer's Disease by Illana Gozes

• Mathematics for Neuroscientists, Second Edition by Fabrizio Gabbiani and Steven J. Cox

• Primer on Cerebrovascular Diseases, Second Edition by Louis R. Caplan, José Biller, Megan Leary, Eng Lo, Ajith Thomas, Midori Yenari and John Zhang

• Translational Immunotherapy of Brain Tumors by John H. Sampson

In order to meet content needs in neuroscience, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of neuroscientists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

Note for Editors Only credentialed media can request eBook review copies by email, sciencereviewcopies@elsevier.com .

About Elsevier Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect , Scopus , ClinicalKey and Sherpath . Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell , more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy . Elsevier is part of RELX Group , a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com .

Image Available: http://www.marketwire.com/library/MwGo/2017/3...0aebed.jpg

Media Contact Pam Foote Publicity Contact, Science & Technology Books, Elsevier footep@reedelsevier.com +1-978-837-8182

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Immunofoco’s Lentiviral Strategy for Cancer Control

Updated Category News Views 109

Revolutionizing Cancer Treatment: Immunofoco's Approach In the battle against B-cell malignancies, the old ways of doing things sometimes just don’t cut it, folks. Enter Immunofoco. At the recent Society for Immunotherapy of Cancer (SITC) 2026 meeting, they laid some ambitious cards on the table with their in vivo T-cell engager (TCE) delivery strategy. Engineering...

Continue Reading
AppLovin Faces Class Action as Promises Fall Short

Updated Category News Views 65

Class Action Shadows AppLovin Over AI Promises What a tangled web AppLovin has woven for itself. Promises of rapid AI advancements and a slick video tool rollout seemed like a done deal back in the early months of 2026. Well, that was until the cracks started to show by August. Promises Made, Promises Broken The saga kicked off on May 6, 2026, with AppLovin's confident...

Continue Reading
Johnine Barnes Joins Prestigious Labor & Employment Fellowship

Updated Category News Views 88

A Nod to Legal Excellence In the world of labor and employment law, notches on the belt come from more than just winning cases. It's about mastering the balance between legal prowess and professional grace—a cocktail that Johnine P. Barnes seems to have perfected. Just this November, Barnes was elected as a fellow of the College of Labor & Employment Lawyers (CLEL), a...

Continue Reading
Claus for a Cause: Respecting Heroes with Holiday Cheer

Updated Category News Views 100

An Unforgettable Holiday Season Veterans Day isn't just a date on the calendar—it's an opportunity to pause and offer genuine thanks to those who've served with honor. This year, as the holiday season rolls around, Gemmy Industries' Claus for a Cause collection is redefining how we show our appreciation. These aren't your ordinary inflatables; they come with a purpose...

Continue Reading
Silicosis Crisis: Legal and Health Ramifications Loom

Updated Category News Views 58

The Hidden Dangers of Artificial Stone Here's the grim truth. Artificial stone countertops, loved by many for their aesthetics in kitchens and bathrooms, have a dark side that’s becoming increasingly hard to ignore. Loaded with more than 90% respirable crystalline silica, these materials spew out toxic dust when cut or polished. Once that dust gets airborne, workers...

Continue Reading
Strauss Group Preps Q3 2026 Earnings Release, Webinar

Updated Category News Views 50

Earnings Are Around the Corner for Strauss Group This thing's been coming down the pipeline, and now it's official: Strauss Group Ltd. (TASE: STRS) is throwing open the curtain on its third quarter numbers come November 25, 2026. Mark the date, folks: it's a Wednesday. And in this game, timings matter a heap more than you'd think. With the financial world constantly...

Continue Reading
Huairen Ceramics: Tech Upgrade Powers Global Aspirations

Updated Category News Views 100

Tech Revolution in Porcelain's Traditional Hearth Imagine robots glazing porcelain and kilns all on autopilot—that's the new norm at Huairen City, Shanxi Province, home to China's formidable porcelain industry. Gone are the days when craftsmen relied solely on their keen senses to judge the right glaze and firing time. The latest technology has disrupted tradition here,...

Continue Reading
Fluence Energy Lawsuit: Investor Unrest Unleashed

Updated Category News Views 112

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 45

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
Shipping Stocks Rise Amid Tight Global Tanker Market

Updated Category News Views 93

Global Tanker Market Challenges Drive Earnings The energy shipping scene's got some heat this quarter, my friends. With crude oil prices getting a decent lift today, some energy shipping players are riding that wave to pretty stellar quarterly results. For those in the know, the global tanker market's choking a bit, making for tight conditions. And when the screws...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Weigh In: The Current Landscape for Riot Platforms

Updated Category News Views 156

Investors Assess the Options Market for Riot Platforms In today’s trading environment, investors have embraced a pessimistic outlook on Riot Platforms (NASDAQ: RIOT). This comes as no surprise given the substantial movements detected in the options market, indicating that something notable might be on the horizon for Riot. The notable activity is significant, showcasing...

Continue Reading
Herantis Pharma's HER-096 Achieves Milestone in Parkinson's Study

Updated Category News Views 255

Herantis Pharma Celebrates Positive Outcomes in Parkinson’s Trial Herantis Pharma has made substantial strides in its quest to develop effective therapies for those living with Parkinson’s disease. The company recently shared exciting topline results from its Phase 1b trial conducted with HER-096, a promising candidate designed to tackle the challenges of this...

Continue Reading
Beezie Unleashes New Innovations in Collectibles Resale Market

Updated Category News Views 293

Beezie Redefines the Collectibles Resale Game In an exciting development within the collectibles market, Beezie is pioneering new approaches to how resellers manage and sell high-value items like trading cards, sneakers, and memorabilia. With its innovative platform, Beezie has introduced gamification and secure vaulting, setting a new standard in the industry....

Continue Reading
Investigation into agilon health, inc.: Your Rights As an Investor

Updated Category News Views 172

Investigating Potential Claims for agilon health, inc. Investors In recent developments, shareholders of agilon health, inc. (NYSE: AGL) find themselves under scrutiny due to potentially misleading information that may have impacted their investments. The Rosen Law Firm, a respected global investor rights legal firm, is actively investigating these possible securities...

Continue Reading
Crédit Agricole S.A. Announces New Share Buyback Initiative

Updated Category News Views 265

Crédit Agricole S.A. Announces New Share Buyback Initiative Crédit Agricole S.A. is set to launch an exciting new chapter in its financial journey. The company has received all necessary supervisory approvals to commence a share repurchase program targeting up to 22,886,191 ordinary shares. This initiative is not only a strategic maneuver but also reflects the...

Continue Reading